Persons With Obesity (PwO) Exploratory Research

Completed

• Conditions: Obesity
• Interventions: Other: No treatment given

• Registration Number: NCT05736120
• Lead Sponsor: Novo Nordisk A/S

Brief Summary

The purpose of this study is to understand the personal flow along the weight loss management journey. A range of variables will be addressed in a survey to explore the weight loss journey, barriers and management. Topics include weight loss strategies and challenges, HCP involvement, and perceptions towards weight loss medications.

Potential participants will be recruited using various online panels. Study participants will be recruited to participate in 2 types of qualitative research.

Phase I: Online bulletin boards (OBB) Phase II: Virtual focus groups (real-time)

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2023-02-09
• Study First Submitted QC: 2023-02-09
• Study Start: 2023-02-19
• Study First Posted: 2023-02-21
• Primary Completion: 2023-04-19
• Study Completion: 2023-04-19
• Status Verified: 2023-05
• Last Update Submitted: 2023-05-11
• Last Update Posted: 2023-05-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
2. Male or female, age above or equal to 18 years at the time of signing informed consent.
3. Current body mass index (BMI) of 25 or greater
4. Not currently pregnant
5. Does not participate in intense fitness or body building program
6. Weight loss not through illness or injury
7. At least somewhat concerned about current weight
8. If no plans for weight loss in the next six months, has made at least 1 weight loss effort in last 5 years
9. Struggling with weight for at least 3 years

Exclusion Criteria

1. Previous participation in this study. Participation is defined as having given informed consent in this study
2. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
3. Does not meet inclusion criteria.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Phase II	No treatment given	Virtual focus groups (real-time)
Phase I	No treatment given	Online bulletin boards (OBB)

Primary Outcome Measures

Name	Time	Method
Description of perceptions, behaviours and awareness related to obesity and obesity management among people living with obesity.	1 day (Phase 2)	90-minute focus group with open-ended response (Phase 2)
Assessment of triggers for people with obesity to request medical therapy and expectations for both therapy available and their weight loss journey.	1 day (Phase 2)	90-minute focus group with open-ended response (Phase 2)

Trial Locations

Locations (1)

Novo Nordisk Investigational Site; 🇮🇳 Bengaluru, India